Results 241 to 250 of about 379,741 (354)

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Bridging Gaps in Migraine Management: A Comprehensive Review of Conventional Treatments, Natural Supplements, Complementary Therapies, and Lifestyle Modifications. [PDF]

Pharmaceuticals (Basel)
Abo-Elghiet F, Elosaily H, Hussein DK, El-Shiekh RA, A'aqoulah A, Yousef EM, Selim HMRM, El-Dessouki AM.   +7 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Molecular Aspects in the Development of Type 2 Diabetes and Possible Preventive and Complementary Therapies. [PDF]

Int J Mol Sci
Simon-Szabó L, Lizák B, Sturm G, Somogyi A, Takács I, Németh Z.   +5 more
europepmc   +1 more source

Knowledge and use of complementary therapies in a tertiary care hospital in France: A preliminary study. [PDF]

Medicine (Baltimore), 2020
Michel-Cherqui M, Had-Bujon R, Mongereau A, Delannoy C, Feliot E, Scotté F, Fischler M.   +6 more
europepmc   +1 more source

THE USE OF COMPLEMENTARY AND ALTERNATIVE THERAPIES IN CHILDHOOD CANCER: A QUESTIONNAIRE BASED ON A DESCRIPTIVE SURVEY FROM THE WESTERN BLACK SEA REGION OF TURKEY

, 2016
Meltem Kürtüncü, Hicran Yıldız, Latife Utaş Akhan   +2 more
openalex   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

Varieties of silence - a mixed-methods study exploring reasons and justifications for nondisclosure of the use of complementary therapies to physicians in Finland. [PDF]

BMC Complement Med Ther
Aarva P, Väänänen T, Pyykkönen M, Kankkunen TT.   +3 more
europepmc   +1 more source

Effectiveness of Su Jok therapy as a complementary approach in postoperative symptom management in surgical nursing: a review

Serpil Kaynarca, Sevcan Avcı Işık
openalex   +1 more source

TERAPI MUZIK SEBAGAI RAWATAN KOMPLEMENTARI DI BIMARASTAN AL-MANSURI PADA ABAD KE 13 MASIHI (Music Therapy as a Complementary Treatment in Bimarastan al-Mansuri during the 13th Century)

, 2019
Mohd Jailani Abdullah, Roziah Sidik Mat Sidek, Azmul Fahimi Kamaruzaman   +2 more
openalex   +1 more source